TSC2 c.1762G>A ;(p.E588K)

Variant ID: 16-2120502-G-A

NM_000548.3(TSC2):c.1762G>A;(p.E588K)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.

Oncotarget
Lim, Sun Min SM; Park, Hyung Soon HS; Kim, Sangwoo S; Kim, Sora S; Ali, Siraj M SM; Greenbowe, Joel R JR; Yang, In Seok IS; Kwon, Nak-Jung NJ; Lee, Jae Lyun JL; Ryu, Min-Hee MH; Ahn, Jin-Hee JH; Lee, Jeeyun J; Lee, Min Goo MG; Kim, Hyo Song HS; Kim, Hyunki H; Kim, Hye Ryun HR; Moon, Yong Wha YW; Chung, Hyun Cheol HC; Kim, Joo-Hang JH; Kang, Yoon-Koo YK; Cho, Byoung Chul BC
Publication Date: 2016-03-01

Variant appearance in text: TSC2: E588K
PubMed Link: 26859683
Variant Present in the following documents:
  • Main text
  • oncotarget-07-10547.pdf
View BVdb publication page